275 related articles for article (PubMed ID: 25015036)
1. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
[TBL] [Abstract][Full Text] [Related]
2. Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression.
Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Sengupta S; Chatterjee J
J Clin Pathol; 2010 Oct; 63(10):894-9. PubMed ID: 20876321
[TBL] [Abstract][Full Text] [Related]
3. Epithelio-mesenchymal transitional attributes in oral sub-mucous fibrosis.
Das RK; Anura A; Pal M; Bag S; Majumdar S; Barui A; Chakraborty C; Ray AK; Sengupta S; Paul RR; Chatterjee J
Exp Mol Pathol; 2013 Dec; 95(3):259-69. PubMed ID: 23994666
[TBL] [Abstract][Full Text] [Related]
4. Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
Gadbail AR; Chaudhary M; Sarode SC; Gondivkar S; Tekade SA; Zade P; Hande A; Sarode GS; Patil S
PLoS One; 2018; 13(7):e0200171. PubMed ID: 30001387
[TBL] [Abstract][Full Text] [Related]
5. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer.
Bag S; Pal M; Chaudhary A; Das RK; Paul RR; Sengupta S; Chatterjee J
J Clin Pathol; 2015 Aug; 68(8):605-13. PubMed ID: 26038241
[TBL] [Abstract][Full Text] [Related]
6. Computer-aided molecular pathology interpretation in exploring prospective markers for oral submucous fibrosis progression.
Anura A; Conjeti S; Das RK; Pal M; Paul RR; Bag S; Ray AK; Chatterjee J
Head Neck; 2016 May; 38(5):653-69. PubMed ID: 25532458
[TBL] [Abstract][Full Text] [Related]
7. Collagen deposition correlates with loss of E-cadherin and increased p63 expression in dysplastic conditions of oral submucous fibrosis.
Chakraborti S; Paul RR; Pal M; Chatterjee J; Das RK
Med Mol Morphol; 2022 Mar; 55(1):20-26. PubMed ID: 34482436
[TBL] [Abstract][Full Text] [Related]
8. Expression of heat shock protein70 in oral submucous fibrosis and oral squamous cell carcinoma: an immunohistochemical study.
Thubashini M; Malathi N; Kannan L
Indian J Dent Res; 2011; 22(2):256-9. PubMed ID: 21891896
[TBL] [Abstract][Full Text] [Related]
9. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
[TBL] [Abstract][Full Text] [Related]
10. Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis.
Jayasooriya PR; Nadeeka Jayasinghe KA; Mudiyanselage Tilakaratne W
J Investig Clin Dent; 2011 Aug; 2(3):171-5. PubMed ID: 25426787
[TBL] [Abstract][Full Text] [Related]
11. Epithelial Distribution of E-Cadherin, p63, and Mitotic Figures in ApoTome Images to Determine the Oncogenic Potentiality of Oral Submucous Fibrosis.
Nag R; Paul RR; Pal M; Chatterjee J; Das RK
Microsc Microanal; 2020 Dec; 26(6):1198-1210. PubMed ID: 33050978
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of prime molecules in cervical lesions towards assessment of malignant potentiality.
Das L; Naskar S; Sarkar T; Maiti AK; Das S; Chatterjee J
J Cancer Res Ther; 2018; 14(2):377-381. PubMed ID: 29516923
[TBL] [Abstract][Full Text] [Related]
13. Endorsing cellular competitiveness in aberrant epithelium of oral submucous fibrosis progression: neighbourhood analysis of immunohistochemical attributes.
Anura A; Kazi A; Pal M; Paul RR; Sengupta S; Chatterjee J
Histochem Cell Biol; 2018 Jul; 150(1):61-75. PubMed ID: 29687243
[TBL] [Abstract][Full Text] [Related]
14. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study.
Pammar C; Nayak RS; Kotrashetti VS; Hosmani J
J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335
[TBL] [Abstract][Full Text] [Related]
15. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
16. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
17. ApoTome to visualize E-cadherin and p63 expression in oral pre-cancer.
Das RK; Pal M; Barui A; Paul RR; Chakraborty C; Ray AK; Chatterjee J
Biotechnol J; 2012 May; 7(5):602-7. PubMed ID: 21898830
[TBL] [Abstract][Full Text] [Related]
18. High expressions of CD105 and VEGF in early oral cancer predict potential cervical metastasis.
Chien CY; Su CY; Hwang CF; Chuang HC; Chen CM; Huang CC
J Surg Oncol; 2006 Oct; 94(5):413-7. PubMed ID: 16967447
[TBL] [Abstract][Full Text] [Related]
19. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
